24/7 Market News Snapshot 08 May, 2025 – PepGen Inc. Common Stock (NASDAQ:PEPG)

May 8, 2025

DENVER, Colo., 08 May, 2025 (www.247marketnews.com) – (NASDAQ:PEPG) are discussed in this article.
PepGen Inc. is experiencing significant upward momentum in the stock market, having opened today at $1.26 before hitting a high of $1.545, reflecting a remarkable spike of 22.62% as trading volumes reached 624.66K shares. This surge is indicative of growing investor interest, particularly following the company’s recent financial disclosures and updates regarding its innovative clinical programs.

As a clinical-stage biotechnology firm focused on developing next-generation oligonucleotide therapies, PepGen is making strides in addressing severe neuromuscular and neurological diseases. The latest corporate updates reveal pivotal advancements in its Enhanced Delivery Oligonucleotide (EDO) technology, especially concerning Myotonic Dystrophy Type 1 (DM1) and Duchenne Muscular Dystrophy (DMD). Dr. James McArthur, President and CEO, emphasized the promising results from the FREEDOM-DM1 study, where initial findings showcased a favorable safety profile and effective splicing correction after treatment. Investors are eagerly anticipating additional results from the 15 mg/kg cohort later this year.

Additionally, PepGen remains committed to clinical excellence, with plans to release more data from the CONNECT1-EDO51 study in the third quarter of 2025, which will provide deeper insights into dystrophin production and its clinical implications.

To reinforce its financial stability while advancing its research, PepGen reported holding $97.8 million in cash and equivalents as of March 31, 2025, sufficient to sustain operations for the upcoming year. The recent addition of industry experts Lisa Wyman and Mitchell H. Finer, PhD, to its board is expected to enhance the company’s strategic initiatives.

With a robust pipeline and promising data on the horizon, PepGen is poised for a transformative impact on the landscape of rare disease treatment in the months to come.

Related news for (PEPG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.